Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Creative Medical Technology Holdings Inc CELZ

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:CELZ)

Creative Medical Technology Holdings Provides Corporate Update

Business Wire March 27, 2024

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

Business Wire March 7, 2024

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

Business Wire March 6, 2024

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

Accesswire December 20, 2023

Creative Medical Technology Holdings Provides Corporate Update

PR Newswire November 15, 2023

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem(TM) ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain

PR Newswire October 10, 2023

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem(TM) (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

PR Newswire September 19, 2023

What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?

Accesswire August 24, 2023

Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update

Accesswire July 13, 2023

Opinion & Analysis (NDAQ:CELZ)

No current opinion is available.

Bullboard Posts (NDAQ:CELZ)

Why Is Diabetes Focused Creative Medical Stock Surging On Th

BREAKING NEWS: $CELZ Why Is Diabetes Focused Creative Medical Stock Surging On Thursday? | BenzingaThursday,@Creative Medical Technology...
whytestocks - March 7, 2024

Top stocks to watch after your lunch LYT, BREA, CELZ, GROM,

News; $CELZ Top stocks to watch after your lunch LYT, BREA, CELZ, GROM, CERO2024-03-07 13:03:37 ET DENVER, Colo., Mar 07, 2024...
whytestocks - March 7, 2024

CELZ..... I see dead people

This will not turn out good
Iseneschal - March 7, 2024

CELZ......this is going to be interrogated ; )

Somebody knew something.....chart history tells me Lots of gaps to fill
Iseneschal - March 7, 2024

Creative Medical Technology Holdings Inc. Announces FDA Auth

News; $CELZ Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy...
whytestocks - March 7, 2024

CELZ ....LoL....Scalp #1

Out at $9.70....Cha Ching
Iseneschal - March 7, 2024